ZOM - Zomedica GAAP EPS of -$0.005 revenue of $4.78M

• Zomedica press release ( NYSE: ZOM ): Q3 GAAP EPS of -$0.005.
• Revenue of $4.78M (+23800.0% Y/Y).
• PulseVet unit sales to Small Animal Veterinarians totaled 13, a 225% increase over its third quarter 2021 Small Animal Veterinarian sales as a standalone company, of 4 units.
• Zomedica ended the third quarter with $158.49 million in cash, cash equivalents, and available for sale securities. Exclusive of the purchase of available-for-sale securities, cash used was primarily driven by operations and the acquisitions of the Assisi and Revo platforms
• Shares -8.58% AH.

For further details see: